Exercise and inflammatory disease

Same author

Cardiac Safety of Chronic Inhibition of the Myostatin-Activin Pathway with Bimagrumab in Healthy Older Adults.

The Journal of clinical endocrinology and metabolism·2026

Same author

Correction: Clinical Classification of Cancer Cachexia: Phenotypic Correlates in Human Skeletal Muscle.

PloS one·2024

Same author

Sarcopenia: no consensus, no diagnostic criteria, and no approved indication-How did we get here?

GeroScience·2023

Same author

Efficacy and safety of iscalimab, a novel anti-CD40 monoclonal antibody, in moderate-to-severe myasthenia gravis: A phase 2 randomized study.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2023

Same author

Lessons Learned While Grieving.

Annals of internal medicine·2023

Same author

Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338).

Clinical pharmacokinetics·2022

Same journal

Proceedings of the Annual Meeting of the American Rheumatism Association.

Arthritis and rheumatism·2020

Same journal

The regional distribution of rheumatologists: what can we do, what should we do?

Arthritis and rheumatism·2013

Same journal

Regional distribution of adult rheumatologists.

Arthritis and rheumatism·2013

Same journal

Clinically significant renal involvement in primary Sjögren's syndrome: clinical presentation and outcome.

Arthritis and rheumatism·2013

Same journal

Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study.

Arthritis and rheumatism·2013

Same journal

Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.

Arthritis and rheumatism·2013

Related Experiment Videos

Exercise and inflammatory disease

Related Concept Videos

Cardiac Safety of Chronic Inhibition of the Myostatin-Activin Pathway with Bimagrumab in Healthy Older Adults.

Correction: Clinical Classification of Cancer Cachexia: Phenotypic Correlates in Human Skeletal Muscle.

Sarcopenia: no consensus, no diagnostic criteria, and no approved indication-How did we get here?

Efficacy and safety of iscalimab, a novel anti-CD40 monoclonal antibody, in moderate-to-severe myasthenia gravis: A phase 2 randomized study.

Lessons Learned While Grieving.

Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338).

Proceedings of the Annual Meeting of the American Rheumatism Association.

The regional distribution of rheumatologists: what can we do, what should we do?

Regional distribution of adult rheumatologists.

Clinically significant renal involvement in primary Sjögren's syndrome: clinical presentation and outcome.

Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study.

Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.

Related Experiment Videos

Exercise and inflammatory disease

Related Concept Videos

Related Articles

Cardiac Safety of Chronic Inhibition of the Myostatin-Activin Pathway with Bimagrumab in Healthy Older Adults.

Correction: Clinical Classification of Cancer Cachexia: Phenotypic Correlates in Human Skeletal Muscle.

Sarcopenia: no consensus, no diagnostic criteria, and no approved indication-How did we get here?

Efficacy and safety of iscalimab, a novel anti-CD40 monoclonal antibody, in moderate-to-severe myasthenia gravis: A phase 2 randomized study.

Lessons Learned While Grieving.

Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338).

Proceedings of the Annual Meeting of the American Rheumatism Association.

The regional distribution of rheumatologists: what can we do, what should we do?

Regional distribution of adult rheumatologists.

Clinically significant renal involvement in primary Sjögren's syndrome: clinical presentation and outcome.

Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study.

Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.